Genetic Diversity May Improve Tx Response in Melanoma

This article originally appeared here.
Share this content:
Genetic Diversity May Improve Tx Response in Melanoma
Genetic Diversity May Improve Tx Response in Melanoma

THURSDAY, Nov. 20, 2014 (HealthDay News) -- Evidence suggests a genetic basis for clinical response to cytotoxic T-lymphocyte antigen 4 (CTLA-4) blockade in melanoma, according to research published online Nov. 19 in the New England Journal of Medicine.

Alexandra Snyder, M.D., of the Memorial Sloan Kettering Cancer Center in New York City, and colleagues performed whole-exome sequencing of tumor tissue and matched blood samples from 64 patients with melanoma who were treated with ipilimumab or tremelimumab.

The researchers found that mutational load was associated with degree of clinical benefit from CTLA-4 blockade (P = 0.01) but by itself did not predict response. Genomewide somatic neoepitope analysis and patient-specific HLA typing were used to identify neoantigens in tumors that had a strong response to CTLA-4 blockade. This signature was validated in a second set of 39 patients with melanoma who received anti-CTLA-4 antibodies. These neoantigens activated lymphocytes from patients treated with ipilimumab.

"A high mutational burden increased the likelihood of the development of specific neoepitopes that would confer clinical benefit from CTLA-4 blockade," writes the author of an accompanying editorial.

Two authors are employees of Bristol-Myers Squibb.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »